“Prescription Drugs: Department of Veterans Affairs Paid About Half as Much as Medicare Part D for Selected Drugs in 2017,” (GAO-21-111, December 2020, .pdf format, 23p.).
January 14, 2021
CAAR – US Government Accountability Office Report – January 14, 2021
December 29, 2020
CAAR – US Agency for Healthcare Research and Quality Brief – December 29, 2020
“Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018,” by William A. Carroll, G. Edward Carroll, and Steven C. Hill (Medical Expenditure Panel Survey Statistical Brief No. 532, December 2020, .pdf and HTML format, 11p.).
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=1271
October 29, 2020
CAAR – Kaiser Family Foundation Issue Brief – October 29, 2020
“Medicare Part D: A First Look at Medicare Prescription Drug Plans in 2021,” by Juliette Cubanski and Anthony Damico (October 2020, HTML format).
August 20, 2020
CAAR – Kaiser Family Foundation Issue Brief – August 20, 2020
“Mail Delays Could Affect Mail-Order Prescriptions for Millions of Medicare Part D and Large Employer Plan Enrollees,” by Juliette Cubanski, Jeannie Fuglesten Biniek, Matthew Rae, Anthony Damico, Brittni Frederiksen, and Alina Salganicoff (August 2020, HTML format).
July 9, 2020
CAAR – US Department of Health and Human Service, Office of Inspector General Report – July 9, 2020
“Loophole in Drug Payment Rule Continues To Cost Medicare and Beneficiaries Hundreds of Millions of Dollars,” (OEI-BL-20-00100, July 2020, .pdf format, 16p.).
April 14, 2020
CAAR – US Government Accountability Office Report – April 14, 2020
“Preventing Drug Diversion: Disposal of Controlled Substances in Home Hospice Settings,” (GAO-20-378, April 2020, .pdf format, 21p.).
April 13, 2020
CAAR – Commonwealth Fund Issue Brief – April 13, 2020
“The Elijah E. Cummings Lower Drug Costs Now Act: How It Would Work, How It Would Affect Prices, and What the Challenges Are,” by Paul B. Ginsburg and Steven M. Lieberman (April 2020, .pdf and HTML format, 8p.).
March 23, 2020
CAAR – Kaiser Family Foundation Issue Brief – March 23, 2020
“Examining Current Medicare Part D Policies for Extended Supplies of Medication,” by Juliette Cubanski, Karyn Schwartz, and Anthony Damico (March 2020, HTML format).
November 27, 2019
CAAR – Kaiser Family Foundation Issue Brief – November 27, 2019
“A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries,” by Meredith Freed, Juliette Cubanski, and Tricia Neuman (November 2019, .pdf and HTML format, 27p.).
October 23, 2019
CAAR – Kaiser Family Foundation Brief – October 23, 2019
“Assessing Drug Price Increases in Medicare Part D and the Implications of Inflation Limits,” by Juliette Cubanski and Tricia Neuman (October 2019, .pdf format, 6p.).
October 1, 2019
CAAR – Commonwealth Fund Chart – October 1, 2019
“Key Provisions of Proposals on Drug Price Negotiation, Inflation Rebates, and Medicare Part D Redesign,” (September 2019, .pdf and HTML format, 2p.).
September 27, 2019
CAAR – US House Committee on Energy and Commerce Hearing Testimony – September 27, 2019
“Making Prescription Drugs More Affordable: Legislation to Negotiate a Better Deal for Americans,” a hearing held September 25, 2019 (witness statements available in .pdf format, video available at the site, running time 4 hours 23 minutes). Note: Hearing starts at the 10:15 mark.
CAAR – Center for Retirement Research at Boston College Issue Brief – September 27, 2019
“Medicare Part D’s Effect on Evergreening, Generics, and Drug Prices,” by Geoffrey T. Sanzenbacher and Gal Wettstein (IB No. 19-14, September 2019, .pdf and Excel format, 7p.).
crr.bc.edu/briefs/medicare-part-ds-effect-on-evergreening-generics-and-drug-prices/
September 26, 2019
CAAR – AARP Public Policy Institute Report – September 26, 2019
“Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2019, .pdf format, 17p.).
www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html
August 22, 2019
CAAR – Australia Institute of Health and Welfare Reports – August 22, 2019
A. “Hospital care for people with dementia 2016–17,” (August 2019, .pdf format, 17p.).
B. “Dispensing patterns for anti-dementia medications 2016–17,” (August 2019, .pdf format, 23p.).
August 19, 2019
CAAR – US Department of Health and Human Services, Office of Inspector General Report – August 19, 2019
“Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2017 Average Sales Prices,” (OEI-03-19-00260, August 2019, .pdf format, 12p.).
August 15, 2019
CAAR – US National Center for Health Statistics Data Brief – August 15, 2019
“Prescription Drug Use Among Adults Aged 40–79 in the United States and Canada,” by Craig M. Hales, Jennifer Servais, Crescent B. Martin, and Dafna Kohen (Data Brief No. 347, August 2019, HTML and .pdf format, 8p.).
August 2, 2019
CAAR – Kaiser Family Foundation Issue Brief – August 2, 2019
“A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries,” by Meredith Freed, Juliette Cubanski, and Tricia Neuman (August 2019, HTML and .pdf format, 27p.).
June 27, 2019
CAAR – AARP Public Policy Institute Report – June 27, 2019
“Rx Price Watch Report: Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans, 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (June 2019, .pdf format, 25p.).
www.aarp.org/ppi/info-2019/trends-in-retail-prices-of-drugs.html?INTCMP=RDRCT-PPI-HEALTH-040919
June 25, 2019
CAAR – Kaiser Family Foundation Issue Brief – June 25, 2019
“How Many Medicare Part D Enrollees Had High Out-of-Pocket Drug Costs in 2017?” by Juliette Cubanski, Tricia Neuman, and Anthony Damico (June 2019, .pdf format, 12p.).
June 19, 2019
CAAR – US Senate Special Committee on Aging Committee Hearing – June 19, 2019
“The Complex Web of Prescription Drug Prices, Part III: Examining Agency Efforts to Further Competition and Increase Affordability,” a hearing held June 19, 2019 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 41 minutes). Note: The hearing begins at the 13:43 mark.
May 30, 2019
CAAR – Center for Retirement Research at Boston College Working Paper – May 30, 2019
“The Effect of Medicare Part D on Evergreening, Generic Entry, and Drug Prices,” by Geoffrey T. Sanzenbacher and Gal Wettstein (WP No.2019-8, May 2019, .pdf and Excel format, 24p.). Note: Links to the abstract and the full text of this paper available at:
May 29, 2019
CAAR – Journal of the American Medical Association Article Abstract – May 29, 2019
“Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019,” by Stacie B. Dusetzina, Haiden A. Huskamp, and Nancy L. Keating (Vol. 321, No. 20, May 28, 2019, p. 2025-2027).
May 23, 2019
CAAR – US National Center for Health Statistics Brief, Report – May 23, 2019
A. “Strategies Used by Adults Aged 65 and Over to Reduce Their Prescription Drug Costs, 2016–2017,” by Robin A. Cohen and Peter Boersma (NCHS Data Brief No. 335, May 2019, .pdf and HTML format, 7p.).
www.cdc.gov/nchs/products/databriefs/db335.htm
B. “Trends in Cancer and Heart Disease Death Rates Among Adults Aged 45–64: United States, 1999–2017,” by Sally C. Curtin (National Vital Statistics Report, Vol. 68, No. 5, May 2019, .pdf format, 8p.).
May 1, 2019
CAAR – US House Committee on Energy and Commerce, Subcommittee on Health Hearing Testimony – May 1, 2019
“Prescription Drug Coverage in the Medicare Program,” a hearing held April 30, 2019 (witness statements available in .pdf format, video of the full hearing available at the site, running time 2 hours 9 minutes). Note: Hearing starts at the 11:10 mark, and ends at the 2:23:50 mark.
April 8, 2019
CAAR – AARP Public Policy Institute Report – April 8, 2019
“Rx Price Watch Report: Trends in Retail Prices of Generic Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update,” by Leigh Purvis, and Dr. Stephen Schondelmeyer (April 2019, .pdf format, 23p.).
www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html
March 21, 2019
CAAR – AARP Public Policy Institute Report – March 21, 2019
“Specialty Drugs in Breast Cancer: Health Care Utilization and Costs in the First Year after Diagnosis,” by Elizabeth Carter and Leigh Purvis (March 2019, .pdf format, 4p.).
www.aarp.org/ppi/info-2019/specialty-drugs-in-breast-cancer-health-care-utilization.html
March 20, 2019
CAAR – Congressional Budget Office Working Paper – March 20, 2019
“Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid: An In-Depth Analysis,” by Anna Anderson-Cook, Jared Maeda, and Lyle Nelson (Working Paper 2019-02, March 2019, .pdf format, 58p.). Note: Links to the abstract and the full text of the paper available at:
March 7, 2019
CAAR – US House Committee on Ways and Means, Subcommittee on Health Hearing Testimony – March 7, 2019
“Promoting Competition to Lower Medicare Drug Prices,” a hearing held March 7, 2019 (witness statements available in .pdf format).
waysandmeans.house.gov/legislation/hearings/promoting-competition-lower-medicare-drug-prices
Video of the full hearing available at (running time 2 hours 19 minutes):
CAAR – US Senate Special Committee on Aging Hearing Testimony – March 7, 2019
A. “The Complex Web of Prescription Drug Prices, Part I: Patients Struggling with Rising Costs,” a hearing held March 6, 2019 (witness statements available in .pdf format, video of the full hearing available on the site, running time 1 hour 56 minutes). Note: The hearing begins at the 16:04 mark.
B. “The Complex Web of Prescription Drug Prices, Part II: Untangling the Web and Paths Forward,” a hearing held March 7, 2019 (witness statements available in .pdf format, video of the full hearing available on the site, running time 1 hour 32 minutes). Note: The hearing begins at the 17:19 mark.
February 1, 2019
CAAR – National Bureau of Economic Research Working Papers – February 1, 2019
Links to an abstract are available. For full text availability check your organization’s library.
A. “How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013,” by Frank R. Lichtenberg (w25483, January 2019, .pdf format, 23p.).
B. “The Impact of a Wartime Health Shock on the Postwar Socioeconomic Status and Mortality of Union Army Veterans and their Children,” by Dora Costa, Noelle Yetter, and Heather DeSomer (w25480, January 2019, .pdf format, 47p.).
C. “Is There a Demand for Reverse Mortgages in China? Evidence from Two Online Surveys,” by Katja Hanewald, Hazel Bateman, Hanming Fang, and Shang Wu (w25491, January 2019, .pdf format, 35p.).
CAAR – Kaiser Family Foundation Issue Brief – February 1, 2019
“The Out-of-Pocket Cost Burden for Specialty Drugs in Medicare Part D in 2019,” by Juliette Cubanski, Wyatt Koma, and Tricia Neuman (January 2019, .pdf and HTML format, 16p.).
January 2, 2019
CAAR – Commonwealth Fund Blog – January 2, 2019
“Proposed Changes to Medicare Part D Would Benefit Drug Manufacturers More Than Beneficiaries,” by Shawn Bishop (January 2019).
November 13, 2018
CAAR – Journal of the American Medical Association Article Abstract – November 13, 2018
“Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial,” by Philippe Martin, Robyn Tamblyn, Andrea Benedetti, Sara Ahmed, and Cara Tannenbaum (Vol. 320, No. 18, November 13, 2018, p. 1889-1898).
jamanetwork.com/journals/jama/article-abstract/2714531
September 27, 2018
CAAR – AARP Public Policy Institute Report – September 27, 2018
“Rx Price Watch Report: Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2017 Year-End Update,” by Leigh Purvis and Dr. Stephen Schondelmeyer (September 2018, .pdf format, 24p.).
www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html
August 22, 2018
CAAR – AARP Public Policy Institute Report – August 22, 2018
“Reducing Potential Overuse of Dementia Drugs Could Lead to Considerable Savings,” by Elizabeth A. Carter and Leigh Purvis (August 2018, .pdf format, 6p.).
www.aarp.org/ppi/info-2018/reducing-potential-overuse-of-dementia-drugs-could-lead-to-consi.html
August 21, 2018
CAAR – Journal of the American Medical Association Article Abstracts – August 21, 2018
A. “Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents,” by Chana A. Sacks, ChangWon C. Lee, Aaron S. Kesselheim, and Jerry Avorn (Vol. 320, No. 7, August 21, 2018, p. 650-656).
jamanetwork.com/journals/jama/article-abstract/2697695
B. “Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia,” by Cécilia Samieri, Marie-Cécile Perier, Bamba Gaye, Cécile Proust-Lima, Catherine Helmer, Jean-François Dartigues, Claudine Berr, Christophe Tzourio, and Jean-Philippe Empana (Vol. 320, No. 7, August 21, 2018, p. 657-664).
August 9, 2018
CAAR – US Department of Health and Human Services, Office of the Inspector General Report – August 9, 2018
“Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2016 Average Sales Prices,” (OEI-03-18-00120, August 2018, .pdf format, 12p.).
June 26, 2018
CAAR – US Senate Committee on Finance Hearing Testimony – June 26, 2018
“Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market,” a hearing held June 26, 2018 (witness statement available in .pdf format, video of the full hearing available at the site, running time 2 hours 13 minutes). Note: The hearing begins at the 20:25 mark.
June 8, 2018
CAAR – US Department of Health and Human Services, Office of Inspector General Report – June 8, 2018
“The Food and Drug Administration Computed Prescription Drug User Fee Rates Accurately,” (A-05-17-00040, June 2018, .pdf format, 4p.).
June 4, 2018
CAAR – US Department of Health and Human Services, Office of Inspector General Brief – June 4, 2018
“Increases in Reimbursement for Brand-Name Drugs in Part D,” (OEI 03 15 00080, June 2018, .pdf format, 15p.).
oig.hhs.gov/oei/reports/oei-03-15-00080.asp
April 26, 2018
CAAR – National Bureau of Economic Research Working Paper – April 26, 2018
Links to an abstract are available. For full text availability check your organization’s library. “The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries,” by Frank R. Lichtenberg (w24536, April 2018, .pdf format, 46p.).
April 25, 2018
CAAR – Public Library of Science (PLoS) Article – April 25, 2018
“Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable,” by Kelly L. Moore, Kanan Patel, W. John Boscardin, Michael A. Steinman, Christine Ritchie, and Janice B. Schwartz (PLoS ONE 13(4): e0196109. doi.org/10.1371/journal.pone.0196109, XML, HTML, and .pdf format, 14p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0196109
March 29, 2018
CAAR – US Senate Committee on Homeland Security and Government Affairs Minority Report – March 29, 2018
“Manufactured Crisis: How Devastating Drug Price Increases Are Harming America’s Seniors,” (March 2018, .pdf format, 11p.).
February 8, 2018
CAAR – Center for Retirement Research at Boston College Issue Brief – February 8, 2018
“How Do Prescription Drugs Affect the Use of Other Health Services?” by Gal Wettstein (IB No. 18-3, February 2018, .pdf format, 8p.).
How Do Prescription Drugs Affect the Use of Other Health Services?
January 29, 2018
CAAR – National Bureau of Economic Research Working Papers – January 29, 2018
Links to an abstract are available. For full text availability check your organization’s library.
A. “Targeting with In-kind Transfers: Evidence from Medicaid Home Care,” by Ethan M.J. Lieber and Lee M. Lockwood (w24267, January 2018, .pdf format, 74p.).
B. “Household Time Use Among Older Couples: Evidence and Implications for Labor Supply Parameters,” by Richard Rogerson and Johanna Wallenius (w24263, January 2018, .pdf format, 55p.).
C. “High-Priced Drugs in Medicare Part D: Diagnosis and Potential Prescription,” by Richard G. Frank and Richard J. Zeckhauser (w24240, January 2018, .pdf format, 41p.).
December 15, 2017
CAAR – AARP Public Policy Institute Report – December 15, 2017
“Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015,” by Stephen W. Schondelmeyer and Leigh Purvis (December 2017, .pdf format, 16p.).
www.aarp.org/ppi/info-2016/trends-in-retail-prices-of-drugs.html
November 7, 2017
CAAR – Kaiser Family Foundation Issue Brief – November 7, 2017
“No Limit: Medicare Part D Enrollees Exposed to High Out-of-Pocket Drug Costs Without a Hard Cap on Spending,” by Juliette Cubanski, Tricia Neuman, Kendal Orgera, and Anthony Damico (November 2017, .pdf and HTML format, 13p.).
October 26, 2017
CAAR – Public Library of Science (PLoS) Articles – October 26, 2017
A. “Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia,” by Susan F. Wood, Joanna Podrasky, Meghan A. McMonagle, Janani Raveendran, Tyler Bysshe, Alycia Hogenmiller, and Adriane Fugh-Berman (PLoS ONE12(10): e0186060. doi.org/10.1371/journal.pone.0186060, HTML, XML, and .pdf format, 13p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0186060
B. “Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany,” by Anne Fink, Nikolaus Buchmann, Christina Tegeler, Elisabeth Steinhagen-Thiessen, Ilja Demuth, and Gabriele Doblhammer (PLoS ONE12(10): e0187119. doi.org/10.1371/journal.pone.0187119, XML, HTML, and .pdf format, 15p.).
journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0187119
October 20, 2017
CAAR – Kaiser Family Foundation Issue Briefs – October 20, 2017
A. “Medicare Part D: A First Look at Prescription Drug Plans in 2018,” by Juliette Cubanski, Anthony Damico, Jack Hoadley, Kendal Orgera, and Tricia Neuman (October 2017, .pdf and HTML format, 21p.).
www.kff.org/medicare/issue-brief/medicare-part-d-a-first-look-at-prescription-drug-plans-in-2018/
B. “Medicare Advantage 2018 Data Spotlight: First Look,” by Gretchen Jacobson, Anthony Damico, and Tricia Neuman (October 2017, .pdf and HTML format, 5p.).
www.kff.org/medicare/issue-brief/medicare-advantage-2018-data-spotlight-first-look/